However, another randomized, double-blind, placebo-controlled trial in 181 patients with diabetic neuropathy found that oral supplementation with either 600 mg/day, 1,200 mg/day, or 1,800 mg/day of lipoic acid for five weeks significantly improved neuropathic symptoms (77)
Immediate and long-term consequences of COVID-19 infections for the development of neurological disease
FOXO4-DRI Human Trials: Status, Evidence Gaps, and What to Watch (2026) As of July 2026, no human trial of FOXO4-DRI has ever been registered or published
Blood thinnerssuch as warfarin or aspirinare essential for reducing the risk of blood clots
*Correspondence: Jianhua Zhang, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers